Quality assessment for risk of bias for studies. by Fei Lin (156666)

Effect of tirzepatide vs placebo on body weight. by Fei Lin (156666)

The results of safety in meta-analysis. by Fei Lin (156666)

Graphs of risk of bias for studies. by Fei Lin (156666)

General baseline of included studies. by Fei Lin (156666)

Prevalence of undesirable behaviors based on C-BARQ subscales. by Kyle R. Bohland (16839147)

LPGA-N₂ isotherms of coal samples. by Jin Wang (29560)

Preventing Protein Oxidation with Sugars: Scavenging of Hypohalous Acids by 5‑Selenopyranose and 4‑Selenofuranose Derivatives by Corin Storkey (1820602)

“…Reaction with HOSCN is slower (∼10² M^–1 s^–1). The seleno-sugars decreased the extent of HOCl-mediated oxidation of Met, His, Trp, Lys, and Tyr residues, and 3-chlorotyrosine formation, on both isolated bovine serum albumin and human plasma proteins, at concentrations as low as 50 μM. …”

Complete Blood Count (CBC) of the affected dogs. by Marjo K. Hytönen (8522271)

Expression of <i>EBI2, CH25H, CYP7B1</i> and <i>HSD3B7</i> enzymes in human brain vascular cells. by Fionä Caratis (12759506)

Association of Long-Term Change and Variability in Glycemia with Risk of Incident Heart Failure among Patients with Type 2 Diabetes Mellitus – A Secondary Analysis of the ACCORD Tr... by Matthew W. Segar (8816108)

N-AChR responses with additional accessory protein combinations. by Jennifer D. Noonan (14117157)

Insights into SARS-CoV-2’s Mutations for Evading Human Antibodies: Sacrifice and Survival by Binquan Luan (1288623)

“…Here, we show that despite the decrease in binding affinity (1.48 kcal/mol) between RBD and ACE2, the K417N mutation abolishes a buried interfacial salt bridge between the RBD and neutralizing antibody CB6. …”

Insights into SARS-CoV-2’s Mutations for Evading Human Antibodies: Sacrifice and Survival by Binquan Luan (1288623)

“…Here, we show that despite the decrease in binding affinity (1.48 kcal/mol) between RBD and ACE2, the K417N mutation abolishes a buried interfacial salt bridge between the RBD and neutralizing antibody CB6. …”

Table 1_Gamma knife radiosurgery for cerebral cavernous malformations: biologically effective dose predicts therapeutic outcomes.docx by Xiaoman Shi (12587770)

“…During follow-up, 13 patients (10.6%) experienced hemorrhage and AHR decreased from 13.6 to 4.3% per 100 lesion-years (IRR = 0.314; p < 0.001). …”

Schematic representation of pAAV-<i>MIR-96</i>-<i>eGFP</i>-int construct and hRPE cells’ transfection. by Zeynab Hosseinpoor (19762319)

R code used for the analysis. by Kelvin Mwangilwa (19259517)

“…A decreased slope was observed in immunization coverage of Rotavirus dose one (RR, 0.97; 95% CI: 0.96–0.98) and Rotavirus dose two (RR, 0.97; 95% CI: 0.96–0.98). …”

Data completeness from 2017 to 2022 by month. by Kelvin Mwangilwa (19259517)

“…A decreased slope was observed in immunization coverage of Rotavirus dose one (RR, 0.97; 95% CI: 0.96–0.98) and Rotavirus dose two (RR, 0.97; 95% CI: 0.96–0.98). …”

Study Flowchart. by Jae-Heung Cho (798319)

“…The CMT group showed significant improvement in specific functional and quality of life measures, particularly in the EuroQoL-VAS (-13.21 (95% confidence interval [CI] -20.03 to -6.38) and the Jaw Functional Limitation Scale-Global score of 0.59 (95% CI 0.13 to 1.05), through improvements were not consistent across all indices. …”

Changes in outcomes over time. by Jae-Heung Cho (798319)

“…The CMT group showed significant improvement in specific functional and quality of life measures, particularly in the EuroQoL-VAS (-13.21 (95% confidence interval [CI] -20.03 to -6.38) and the Jaw Functional Limitation Scale-Global score of 0.59 (95% CI 0.13 to 1.05), through improvements were not consistent across all indices. …”